Winning HCLS Commercial Teams Are Going Agentic in 2026

AI Agents and Revenue Operations for Healthcare & Life Sciences

More pipeline. Better intel. Zero new headcount. Built by HCLS operators with 60+ years spanning IC to VP across sales, marketing, and customer success – we’ve lived the problems these agents and services solve.

Get in Touch Services & Pricing
Zero footprint on your systems • First report within a week • Customized to your ICP, territories, and sales playbook
43Qualified Opps in 2.5 Months
56%Cold Email Open Rate
200K+Leads Sequenced Across Clients
90Qualified MQLs in 6 Months
40%YOY Revenue Growth
19.2%Increase in Website Traffic from Campaigns Over 6 Months
266%Traffic Increase in 6 Months
2,400Publication-Matched Leads for a Single Campaign
79%Net New Visitors from 6-Month Campaign
50%Google Ads Cost Reduction
300%Lead Gen vs. Goal
16,000Leads Sequenced in a Single Engagement
2 days → 30 minForecasting Time per Territory Manager
43Qualified Opps in 2.5 Months
56%Cold Email Open Rate
200K+Leads Sequenced Across Clients
90Qualified MQLs in 6 Months
40%YOY Revenue Growth
19.2%Increase in Website Traffic from Campaigns Over 6 Months
266%Traffic Increase in 6 Months
2,400Publication-Matched Leads for a Single Campaign
79%Net New Visitors from 6-Month Campaign
50%Google Ads Cost Reduction
300%Lead Gen vs. Goal
16,000Leads Sequenced in a Single Engagement
2 days → 30 minForecasting Time per Territory Manager

From Signal to Meeting

Your autonomous commercial intelligence agent runs this pipeline end-to-end. Five stages, all AI-driven, tuned by 60+ years of HCLS operator judgment.

Zero Footprint on Your Systems: Managed Intelligence runs entirely on our infrastructure. No IT involvement, no security review, no integrations required – your team just receives the report. For Build + Transfer clients who need full control, we deploy on your VPC or a dedicated single-tenant server with end-to-end encryption.

Intel Cards

Sample cards from a real agent delivery. Reps get territory-level intel – expansion signals, net-new prospects, and HCP/KOL targets – each with named contacts and a specific entry angle. Sales leadership gets strategic deep dives with persona mapping and CRM activity flags, plus a worldwide view surfacing cross-territory opportunities and coverage gaps.

Expansion Signal

Genentech / Roche

South San Francisco, CA • IN CRM
Expansion · XL Hiring · 3 Open Roles Phase 3 Trials
Why Now
$50B U.S. investment announced (Jan 2026). 6+ new sites under construction, Oceanside biologics facility breaking ground Q2 2026. Bispecific antibody portfolio entering late-stage trials. Analytical demand scaling across manufacturing.
Opportunities by Territory
West: South San Francisco (HQ) – existing relationship, platform expansion
West: Oceanside, CA – new biologics manufacturing, breaking ground 2026
East: Cambridge, MA – new clinical biotech hub, hiring analytical leads
Midwest: Vacaville, CA – fill/finish expansion, 2 open LC-MS roles
Global: Basel, Switzerland – Roche parent, central procurement
Key Contact
James Whitfield, VP, Analytical Development
LinkedIn •••••• j.whitfield@••••.com IN CRM
Opportunity Size
XL: 6+ sites, multi-department
Sources Cross-Referenced
SEC EDGAR Job Boards Industry News ClinicalTrials.gov Financial Data AI Research
Entry Angle
“Your South San Francisco team already uses [product] in discovery. With 6 new sites coming online, the manufacturing teams are making analytical software decisions now. Worth a conversation before PEGS?”
LinkedIn IN CRM
Net-New Prospect

Crescent Biopharma

Waltham, MA • NEW
Series B: $400M+ · Nov 2025 IND Cleared · Jan 2026 Hiring · 3 Analytical Roles
Why Now
IND cleared January 2026 for lead ADC candidate. $400M+ Series B closed November 2025. Building CMC and analytical infrastructure from scratch. No legacy vendor lock-in. Actively hiring analytical scientists.
Key Contact
Rachel Torres, Head of CMC
LinkedIn •••••• r.torres@••••.com NEW
Opportunity Size
M-L: Greenfield build, no incumbent
Event Hook
Crescent presenting preclinical ADC data at AACR 2026 (April). CMC team evaluating vendor partnerships through Q2.
Sources Cross-Referenced
FDA CDER SEC Form D Job Boards Industry News AI Research
Entry Angle
“Congratulations on the IND clearance. As you build out CMC, the analytical stack decisions you make now carry through to commercial. Happy to share how similar-stage biotechs have approached it.”
LinkedIn NEW
Target HCP / KOL

Dr. Sarah Chen, MD, PhD

VP, Translational Medicine • Top-20 Biopharma • IN CRM
ASCO 2026 Speaker · May 2026 3 Publications · 2025–2026 KOL · Advisory Board
Why Now
Presenting on translational biomarker strategies at ASCO 2026 (May, Chicago). Published 3 papers since March 2025 on companion diagnostics for ADC therapies. Most recent (Dec 2025, JCO) cited your competitor’s assay platform, but flagged limitations in clinical sensitivity.
CRM History
Closed-lost: $45K opp from 18 months ago (lost to [competitor] on sensitivity specs). Demo completed, champion was her direct report. Contact record exists but marked inactive. Last email opened 6 months ago.
Key Contact
LinkedIn •••••• s.chen@••••.com (858) •••–•••• San Diego, CA
Professional Network
MD (Stanford), PhD Immunology (MIT). 15 years spanning clinical practice and biopharma R&D. Previously at Regeneron (Associate Medical Director) and Genentech (Clinical Scientist). Active KOL in oncology. Advisory board for 2 FDA-approved therapies. Publishes in NEJM, JCO, and Nature Medicine.
Opportunity Size
M: Platform evaluation, potential site-wide adoption
Connection Path
2nd-degree LinkedIn connection via your West Coast rep. Co-authored with a clinician your MSL met at AACR 2025. Her former Regeneron colleague is a current customer. Warm intro available.
Event Hook
Presenting on translational biomarkers at ASCO 2026 (May, Chicago). Also chairing a companion diagnostics symposium at AACR in April. Both are pre-conference outreach windows.
Sources Cross-Referenced
Your CRM PubMed ClinicalTrials.gov Conference Agendas Google Scholar AI Research
Entry Angle
“Dr. Chen, your JCO paper on companion diagnostic sensitivity for ADC patient selection was excellent. You flagged the exact limitation we’ve helped 3 oncology teams solve this year. I see you’re presenting at ASCO in May. Would love to connect beforehand.”
LinkedIn IN CRM
Strategic Deep Dive

Full Account Dossier: Meridian Biologics

Priority account selected by your sales leader. 12 named personas mapped by department and influence level, competitive landscape, and tailored outreach hooks.
Persona Map (12 Contacts)
Why Deep Dives Matter
Monthly reports surface the signal. Deep dives turn it into a strategy. Your rep walks into this account knowing who to call, what to say, and where the competitor is vulnerable – not just that the company is growing.
What’s Included
▶ 8-15 named personas with titles, LinkedIn, email, and entry angles
▶ Competitive software map with contract timing and satisfaction signals
▶ Facility-level opportunity breakdown
▶ CRM activity summary – open opps, last contact, marketing engagement, and stalled deal flags
▶ Outreach hooks tailored to each persona type
▶ Every claim sourced – SEC filings, job postings, conference proceedings, press releases
Included in Every Tier
PoC: 1 deep dive (you pick the account)
Standard: 1 deep dive per month
Premium: 3 deep dives per month
Sources Cross-Referenced
Your CRM SEC EDGAR FDA ClinicalTrials.gov Job Boards Industry News Conference Proceedings Financial Data AI Research
Worldwide View: Sales Leadership

Cross-Territory Signals Your Reps Can’t See

Aggregated from every rep’s territory. Surfaces accounts where your network, stalled deals, or cross-territory overlap creates leverage only you can act on.
Why This View Matters
Commercial leaders have relationships that reps don’t. This card surfaces accounts where your personal network (LinkedIn connections, conference history, former colleagues) creates an inroad that cold outreach can’t match.
One message from you to a former colleague can do what 30 emails from a rep cannot. The agent finds these moments so they don’t slip by.
What Your Team Sees vs. What You See
Rep card: Account signals, contacts, entry angles
Your card: All of the above + where your network creates leverage, stalled deals you can unstick, and re-engagement opportunities only you can open
LinkedIn Network Matching
Premium feature: We cross-reference your LinkedIn connections against every account in the report. When your network overlaps with a target account, it shows up here with a specific action you can take.
Sources Cross-Referenced
Your CRM LinkedIn Network Team Pipeline SEC EDGAR FDA ClinicalTrials.gov Job Boards Industry News Financial Data AI Research

Sample cards based on real agent deliveries. Names and details are illustrative. Your cards are tailored to your products, territory, CRM, and ICP. Every card cross-references your CRM, external signals, your reps’ network, and your sales playbook. That’s what makes it actionable, not just informational.

Why Now

AI leaders are already pulling ahead. BCG reports they achieve 1.7x the revenue growth of laggards, and the gap is widening quarterly.

Your team is manually tracking signals across dozens of sources

AI agents monitor everything. Overnight.

Regulatory approvals, SEC filings, clinical trials, funding rounds, executive moves, job postings, press releases, product launches, conference announcements, social media, and partnership signals. Filtered to your territory before your first meeting.

Result: 2,400 evidence-matched leads for a single client

Salesforce reports 30% of HCLS sales effort fails to target the intended decision maker or leverage the appropriate messaging

Science-matched targeting changes the math

Prospects matched to their own publications, conference talks, and research grants. Every touchpoint references something real, not a template. Industry average cold email open rate is ~23%. Ours hit 56%.

Result: 56% open rate • 2.4x industry average

Only 22% of life sciences execs have scaled AI. Just 9% see returns (Deloitte, 2026)

The window for first-mover advantage is now

McKinsey found only 6% of organizations capture real value from AI. The difference isn’t the technology. It’s having operators who know your workflows build the system. We’ve done it 6 times in HCLS and counting.

Result: 43 new opps in 2.5 months from a standing start

Sources

BCG: AI Leaders Outpace Laggards (2025) McKinsey: State of AI (2025) Deloitte: Life Sciences Outlook (2026) Salesforce: HCLS AI Survey (2025) Bain: Commercial AI Winners (2025) ZS: Scaling AI in Pharma (2026)

What We Build, and What It Costs

Transparent pricing. Every engagement starts with your team’s actual needs.

Commercial Intelligence Agents

Expansion signals, net-new prospects, account deep dives, and competitive landscape – matched to your ICP and sales territories. Live in 2–3 weeks.

What You Get

  • Expansion signals in existing accounts + ranked net-new prospects matched to your ICP
  • Named decision-makers with LinkedIn, email, entry angles, and CRM status
  • Account deep dives: competitive landscape, persona mapping, conference intel, and outreach hooks
  • Branded, territory-specific HTML reports – forward to reps or print for team meetings

Why This Isn’t DIY (Your In-House LLMs)

  • 25+ live data sources refreshed monthly – government & regulatory APIs, job intelligence platforms, industry news feeds, financial data, and AI-powered deep research – not months-old training data
  • Dedicated fact-check pass on every figure, name, and company detail – no hallucinated contacts
  • Cumulative memory across reports – each month builds on the last instead of starting from scratch
  • Your install base cross-referenced on every run – expansion signals are real customers, net-new prospects aren’t
Protein Analysis Company: Expansion intelligence across 5 key accounts, 7 ranked net-new prospects matched to ICP, and a full account dossier with named personas and outreach hooks. Delivered in one session.
Pharma Field Team: Territory-level competitive intelligence: HCP targets, key account signals, and KOL activity. Replacing hours of weekly manual research with overnight autonomous delivery.

Managed Intelligence – Standard

$3,500/mo$33,600/yr
Per month$2,800/mo effective – Save $8,400/yr
  • Monthly tabbed report with per-rep territories
  • 1 account deep dive per month (you pick)
  • Expansion signals + net-new prospects
  • Tuned monthly from your feedback – gets smarter over time
YOUR LIFT: NEAR ZERO
Share customer list, confirm priority account, forward reports to reps. No IT, no security review. Zero footprint on your systems.

Managed Intelligence – Premium

$5,000/mo$48,000/yr
Per month$4,000/mo effective – Save $12,000/yr
  • Everything in Standard
  • 3 account deep dives per month (2 additional)
  • Monthly strategic review call (30 min)
  • LinkedIn network matching (optional) – see which contacts your reps already know
YOUR LIFT: NEAR ZERO
Same as Standard, plus 30 min/month strategic review. No IT, no security review. Zero footprint on your systems.

Build + Transfer

$15,000 – $25,000
One-time + $1,500/mo advisory
  • Full agent stack on your infrastructure
  • Team training, docs, and IP transfer
  • Advisory retainer for ongoing tuning
  • You own the agents and data pipeline
YOUR LIFT: SIGNIFICANT
IT involvement required. Your team maintains infrastructure, API keys, and model costs.
Start with a $2,500 Proof of Concept
Full Standard deliverable delivered within a week. Your team works the intel for the rest of the month. If it drives action, the $2,500 is credited toward your subscription. If not, you keep the report.
Get Started

Lead Generation

Find the right people, at the right companies, at the right time, and get your reps in front of them.
  • Prospects matched to their own publications, conference talks, grants, and research, so every touchpoint references something real, not a template
  • KOL identification, key account mapping, and HCP targeting using NPI databases, SciLeads, and your existing data subscriptions
  • Multi-channel campaigns across email, LinkedIn, and phone, built on proven HCLS outreach methodology
  • Real-time dashboards for engagement tracking, MQL/SQL routing, and pipeline visibility
  • Full infrastructure setup: domain warm-up, deliverability optimization, and sequencing tools so you launch clean
VC-Backed Single-Cell Biotech: 16,000 leads, 43 new opportunities, and 90 qualified MQLs in 2.5 months. Sales cycles under 60 days.
Protein Analysis Company: 2,400 publication-matched leads, 56% open rate (2.4x industry average), and 4 orders won from a single cold email campaign.
$10K – $25K

Project-based. Scoped to your ICP, channels, and campaign goals.

Let’s Scope It

Growth Marketing

Demand gen built for scientific buyers: campaigns that educate researchers and convert them into pipeline.
  • Content and messaging strategy designed for technical audiences: application notes, workflow guides, and campaign pages that speak the language of your buyers
  • Pre- and post-conference outbound campaigns tied to specific events (AACR, ASHG, SLAS, ASCO, and beyond)
  • Google and LinkedIn advertising optimized for scientific search terms and researcher audiences
  • SEO and website optimization: landing pages, forms, CTAs, and conversion tracking built for how scientists actually browse
  • Marketing automation setup and optimization (HubSpot, Marketo, Pardot): lead scoring, nurture sequences, and MQL routing
  • Account-based marketing campaigns targeting named accounts with personalized content
Life Science Tools Company: 6 campaign pages drove 19.2% of total website traffic with 79% new users.
Project-based or fractional retainer

Scoped to your campaigns, channels, and growth targets.

Let’s Scope It

Sales Operations

Pipeline visibility and forecasting your leadership can actually trust, built by people who’ve used these dashboards to run territories.
  • Full CRM build, migration, and automation: Salesforce, HubSpot, Veeva, or Dynamics
  • Forecasting dashboards tied to monthly goals with commit, best case, and pipeline views
  • Territory planning, lead scoring, and account segmentation
  • Sales process documentation, onboarding playbooks, and rep ramp programs
  • CS and renewal dashboards: track customer health, expansion signals, and churn risk
  • Reporting and analytics in Power BI, Tableau, or native CRM dashboards
AI Medical Scribe Platform: Built dashboards for Sales, Marketing, and Executive teams. Forecasting time cut from 2 days to 30 minutes per territory manager. First-ever visibility into deal velocity.
Project-based or fractional retainer

Scoped to your CRM, pipeline, and reporting needs.

Let’s Scope It

Client Results

Outcomes from HCLS commercial teams. From first engagement to measurable impact.

VC-Backed Single-Cell Biotech

Sales Pipeline from Zero to 43 Opportunities

43 Qualified Opps 2x $100K Orders in 60 Days In 2.5 Months
“Created a significant sales funnel from scratch, in a scalable and trainable way which allowed our team to take over and continue growing it independently.”
– Co-Founder & CSO
Hover front for stats
AI Medical Scribe Platform

From No CRM to Full Pipeline Visibility

Deal Velocity Tracking Revenue Forecasting 3 Team Dashboards
“Gave us a foundation from which to measure performance, in general and more systematically, which helped us understand foundational dynamics with regard to sales performance, deal velocity, and forecasting.”
– SVP & Head of Sales
Hover front for stats
Microfluidic Flow Cytometry

40% Revenue Growth, 3 Sales Hires Onboarded

40% YOY Growth 3 Reps Hired & Trained On Scope & Budget
“Best in class for our small size company. On scope, on time, on budget.”
– VP Commercial
Hover front for stats
Protein Analysis Technology

56% Open Rate, 2.4x Industry Average

56% Open Rate 2,400 Publication-Matched Leads 4 Orders Won
2,400 validated leads from evidence-matched scientific publications. 5-email sequence ramped to 100 daily sends. 4 order submissions including 1 new customer.
– Co-Founder & CEO
Hover front for stats
Life Science Tools Company

6 Campaigns Drove 19.2% of All Website Traffic

3,246 Campaign Sessions 79% New Visitors 6 Campaign Pages
6 linked campaign pages driving 3,246 sessions. Top performer: Live Cell Painting (1,252 sessions). CTA pages: Shop (614 sessions), Contact Us (204 sessions).
– Head of Marketing
Hover front for stats

The Team

Operators who’ve carried the bag, managed the territory, and built the systems.

Trey Knollman

Trey Knollman

Founder & AI Agent Architect
Seattle, WA

18 years inside HCLS companies spanning bench to boardroom. Scientist at Thermo Fisher ($200B+ market cap, 6 product launches). Commercial leader at Essen BioScience (acquired by Sartorius for $320M). Worldwide Rookie of the Year at IntelliCyt (acquired by Sartorius for $90M), then West Region Director at Sartorius (#1 region, 147% quota). Sales Director at IsoPlexis ($111M IPO). National Sales Manager at NanoCellect ($78M raised, 40% YOY revenue growth). VP Sales at Amplion ($0→$500K ARR, acquired by Science & Medicine Group).

Flow cytometry, single-cell analysis, genomics/proteomics, diagnostics, digital health, SaaS
LinkedIn →
Sohiel Memarsadeghi

Sohiel Memarsadeghi

Partner
San Francisco, CA

Biomedical engineering researcher turned commercial leader. Published in Analytical Chemistry (U of Michigan, NIH-funded). 17 years at Essen BioScience (acquired by Sartorius for $320M), building new territories and consistently surpassed targets on the IncuCyte platform. Senior Technical Sales Engineer at Nodexus ($30M Series A, RA Capital), commercializing single-cell sorting for CRISPR and cancer biology. Instructor at the University of San Francisco, co-developing biotech curriculum funded by a $2M gift from Essen’s co-founder.

Cell biology, single-cell workflows, live-cell analysis, gene editing, cancer biology, biomedical engineering
LinkedIn →
Kurt Harris

Kurt Harris

Partner
Chicago, IL

40+ year career spanning life sciences, diagnostics, and scientific instrumentation at the enterprise level. President’s Club winner at Integrated DNA Technologies (acquired by Danaher for $1.9B). Currently at Revvity ($11B market cap, formerly PerkinElmer). Led product strategy and sales at RURO (acquired by Azenta for $15M). Known for rapidly mastering complex portfolios and devising go-to-market strategies across genomics, LIMS, and detection platforms.

Enterprise sales, genomics, radiometric detection, LIMS, scientific instrumentation, strategic partnerships
LinkedIn →

Frequently Asked Questions

Common questions from HCLS commercial leaders evaluating AI agents and revenue operations.

AI agents are autonomous software systems that monitor market signals overnight – FDA approvals, SEC filings, clinical trial milestones, funding rounds, hiring surges, conference announcements, and more – then enrich and score those signals against your ICP, territory, and CRM data. By morning, your reps get actionable intel cards with named decision-makers, outreach hooks, and recommended next steps. Unlike traditional sales tools that require manual research, AI agents work 24/7, cross-reference dozens of sources, and deliver ready-to-act intelligence tailored to your commercial processes.
Our Commercial Intelligence agents follow a 5-stage pipeline: (1) data collection from 25+ sources including regulatory databases, job boards, industry news feeds, financial filings, and clinical trial registries; (2) signal processing that filters thousands of data points through your ICP definition, install base, and territory map; (3) three parallel research agents running simultaneously – expansion signals, net-new prospects, and a deep account dossier – each with domain-specific prompting built on 60+ years of HCLS experience; (4) a dedicated fact-check agent that independently verifies every figure, contact, and company detail against public sources; and (5) territory-ready HTML reports tabbed by rep, with a worldwide view for sales leadership. One client went from zero pipeline to 43 qualified opportunities in 2.5 months using this system.
Every engagement starts with a $2,500 Proof of Concept – a full report delivered within a week so your team can evaluate real output, not a demo. If you continue, the $2,500 is credited toward your subscription. Managed Intelligence runs $3,500–$5,000/month (Standard or Premium) with a 20% discount on annual commitments. Build + Transfer is $15,000–$25,000 one-time plus $1,500/month advisory for teams that want to own the agent stack. No lock-in contracts.
For Managed Intelligence (Standard and Premium), there is zero integration required – we cross-reference your install base and CRM exports, then deliver standalone HTML reports your team can open anywhere. No IT involvement, no security review, no software to install. For Build + Transfer clients who want full integration, our agents connect to Salesforce, HubSpot, Veeva, and Dynamics 365, plus your existing data subscriptions. Signals are cross-referenced against your CRM history so reps see open opportunities, stalled deals, and past interactions alongside new market intelligence. Build + Transfer deploys on your VPC or a dedicated single-tenant server with end-to-end encryption.
Traditional sales automation (sequences, cadence tools, CRM workflows) executes predefined steps. AI agents reason autonomously: they discover signals your team didn’t know to look for, cross-reference multiple data sources in real time, and generate personalized outreach anchored to each prospect’s publications, conference talks, or regulatory milestones. The result is outreach that references something real – not a template – which is why our clients see 56% email open rates versus the 23% industry average.
We provide full-service revenue operations across three areas. Lead Generation: science-matched prospecting, KOL targeting, and multi-channel campaigns with end-to-end infrastructure – domains, deliverability, sequencing, and reporting. Growth Marketing: demand gen built for researchers and clinicians, including conference campaigns, paid media, SEO, and marketing automation with lead scoring and nurture workflows. Sales Operations: CRM implementation and optimization, revenue forecasting dashboards, territory planning, pipeline analytics, rep onboarding, and customer success tracking. Everything is purpose-built for HCLS commercial teams by operators who have run these functions themselves for over 60 years combined.
Your first report is delivered within a week of kickoff – no integration, no onboarding delays. From there, the agent gets sharper as it learns your ICP, install base, and territory structure. One analytical instruments client went from zero outbound pipeline to 43 qualified opportunities in 2.5 months. A protein analysis company saw a 56% cold email open rate within the first campaign cycle. Because the agent runs autonomously overnight, your team starts every week with fresh, territory-ready intelligence instead of spending hours on manual research.
We have built and run commercial teams in analytical instruments, flow cytometry, single-cell analysis, genomics, proteomics, diagnostics, digital health, pharma services, and medtech – at companies including Thermo Fisher, Sartorius, Bio-Rad, and multiple venture-backed startups. That operating experience is what makes the intelligence useful. We know which FDA approval is a buying signal versus noise, which conference talks indicate budget authority, and which hiring patterns signal expansion. The agents are prompted with that context, not generic templates.
Every report passes through a dedicated fact-check agent before delivery. This verification agent independently cross-checks every contact name, title, company detail, and market claim against public sources – SEC filings, FDA databases, ClinicalTrials.gov, LinkedIn, and company websites. Contacts include source tags showing exactly where each data point originated. If a claim cannot be verified, it gets flagged or removed – never guessed. On top of that, our team reviews every report with the same judgment we used managing territories and running commercial teams. We catch things a generic system would miss because we have sold into these accounts ourselves.

Let’s Talk

Whether you need an AI agent, a full commercial engine, or want to explore what’s possible, start here.

Start a Conversation →

Let’s Talk

Tell us a bit about your team and we’ll reach out within 24 hours.